Advertisement
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients
Two-year event-free survival comparable to matched sibling donor myeloablative transplant
3 pediatric gastroenterologists discuss advances in their diagnostic toolkits
First-in-human trials of CRISPR-Cas12a gene editing demonstrate safety and meaningful event-free survival
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Early projects include predicting cardiac arrest, kidney injury and low cardiac output syndrome after surgery
JAMA study adds new data to decades-long guidance
Chemicals in e-cigarettes weaken the epithelial barrier in airways
What factors can be modified to improve outcomes?
New course highlights role of imaging in the diagnosis and management in TOF
Cleveland Clinic physicians offer their insights
Advertisement
Advertisement